what are the pros and cons of glp 1 Not all GLP-1 drugs work same way. A new meta-analysis 262 clinical trials highlights why choosing the right treatment should always be based on individual health needs not trends Pros and cons of using

Type 2 Diabetes segment held a market size of USD 19.53 Billion in 2025, accounting for 52% share of the GLP-1 Drug Market, and is projected to grow at a CAGR of 25.8% supported by increasing prevalence and strong clinical outcomes

After detailed deliberation, based on the outcome of the said inspection, the Committee recommended for grant of permission to manufacture and market Semaglutide Tablets 3 mg, 7 mg and 14 mg for the following indication: "Oral Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus

Iakovleva V, Wuestefeld A, Ong ABL, Gao R, Kaya NA, Lee MY, et al (2023) Mfap4: a promising target for enhanced liver regeneration and chronic liver disease treatment

| NBC News